BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 16423463)

  • 1. Genetic study of Sardinian patients with Alzheimer's disease.
    Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
    Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genes in Alzheimer's disease].
    Hoenicka J
    Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
    Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
    Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer's disease. Present and future role of genetics].
    Roks G
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
    Tabira T
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease.
    Howell WM; Brookes AJ
    Am J Med Genet; 2002 Aug; 111(2):157-63. PubMed ID: 12210343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of Alzheimer's disease.
    Goate AM
    Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
    Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
    Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
    Scacchi R; Gambina G; Moretto G; Corbo RM
    Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors and a polygenic model of Alzheimer's disease].
    Rogaev EI
    Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.
    Ezquerra M; Lleó A; Castellví M; Queralt R; Santacruz P; Pastor P; Molinuevo JL; Blesa R; Oliva R
    Arch Neurol; 2003 Aug; 60(8):1149-51. PubMed ID: 12925374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population.
    Wu X; Jiang S; Lin S; Tang G; Feng G; Qian Y; Wang D; Ren D; Gu N
    Am J Med Genet; 1999 Feb; 88(1):1-3. PubMed ID: 10050959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and genetics of Alzheimer disease].
    Myhre A; Tysnes OB
    Tidsskr Nor Laegeforen; 2002 Jan; 122(1):50-3. PubMed ID: 11851296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
    Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
    Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE).
    Reznik-Wolf H; Treves TA; Shabtai H; Aharon-Peretz J; Chapman J; Davidson M; Barkai G; Hyslop PH; Goldman B; Korczyn AD; Friedman E
    Eur J Hum Genet; 1998; 6(2):176-80. PubMed ID: 9781063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N; Sleegers K; Van Broeckhoven C
    Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.